List of Figures
Number of Products under Development for Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection, H1 2016 9
Number of Products under Development for Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Comparative Analysis, H1 2016 10
Number of Products under Development by Companies, H1 2016 11
Number of Products under Investigation by Universities/Institutes, H1 2016 12
Comparative Analysis by Early Stage Products, H1 2016 14
Assessment by Monotherapy Products, H1 2016 25
Number of Products by Targets, H1 2016 27
Number of Products by Stage and Targets, H1 2016 27
Number of Products by Mechanism of Actions, H1 2016 29
Number of Products by Stage and Mechanism of Actions, H1 2016 29
Number of Products by Routes of Administration, H1 2016 31
Number of Products by Stage and Routes of Administration, H1 2016 31
Number of Products by Top 10 Molecule Types, H1 2016 33
Number of Products by Stage and Top 10 Molecule Types, H1 2016 33


List of Tables
Number of Products under Development for Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection, H1 2016 9
Number of Products under Development for Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Comparative Analysis, H1 2016 10
Number of Products under Development by Companies, H1 2016 11
Number of Products under Investigation by Universities/Institutes, H1 2016 12
Comparative Analysis by Clinical Stage Development, H1 2016 13
Comparative Analysis by Early Stage Development, H1 2016 14
Products under Development by Companies, H1 2016 15
Products under Investigation by Universities/Institutes, H1 2016 16
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline by CEL-SCI Corporation, H1 2016 17
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline by GeneCure LLC, H1 2016 18
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline by Humabs BioMed SA, H1 2016 19
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline by Inovio Pharmaceuticals, Inc., H1 2016 20
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline by Nanotherapeutics, Inc., H1 2016 21
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline by Novavax, Inc., H1 2016 22
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline by Phelix Therapeutics, LLC, H1 2016 23
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline by Protein Sciences Corporation, H1 2016 24
Assessment by Monotherapy Products, H1 2016 25
Assessment by Combination Products, H1 2016 26
Number of Products by Stage and Target, H1 2016 28
Number of Products by Stage and Mechanism of Action, H1 2016 30
Number of Products by Stage and Route of Administration, H1 2016 32
Number of Products by Stage and Molecule Type, H1 2016 34
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Therapeutics - Recent Pipeline Updates, H1 2016 53
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Dormant Projects, H1 2016 54
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Dormant Projects (Contd..1), H1 2016 55
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Discontinued Products, H1 2016 56